Free cash flow
AbbVie Free cash flow decreased by 26.4% to $4.89B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 27.6%, from $6.76B to $4.89B. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -5.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests strong operational efficiency and the ability to self-fund future innovation or return capital to shareholders, while a decrease may indicate heavy capital expenditure cycles or declining operational profitability.
Detailed definition
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Peer comparison
High-growth semiconductor and AI infrastructure peers typically prioritize reinvestment, so free cash flow margins are often compared against R&D intensity and capital expenditure requirements of industry rivals.
cf_free_cash_flowHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.70B | $7.72B | $4.89B | $4.75B | $4.86B | $7.43B | $7.22B | $4.02B | $6.14B | $7.36B | $4.55B | $3.85B | $2.03B | $5.20B | $6.76B | $1.40B | $4.88B | $6.64B | $4.89B |
| QoQ Change | — | +64.4% | -36.7% | -2.9% | +2.4% | +52.7% | -2.8% | -44.3% | +52.8% | +19.8% | -38.2% | -15.4% | -47.2% | +156.1% | +30.0% | -79.3% | +248.9% | +36.0% | -26.4% |
| YoY Change | — | — | — | — | +3.6% | -3.8% | +47.6% | -15.3% | +26.3% | -0.9% | -37.0% | -4.3% | -66.9% | -29.3% | +48.6% | -63.6% | +140.6% | +27.8% | -27.6% |
Free cash flow at Other Companies
Frequently Asked Questions
- What is AbbVie's free cash flow?
- AbbVie (ABBV) reported free cash flow of $4.89B in Q4 2025.
- How has AbbVie's free cash flow changed year-over-year?
- AbbVie's free cash flow decreased by 27.6% year-over-year, from $6.76B to $4.89B.
- What is the long-term trend for AbbVie's free cash flow?
- Over 4 years (2021 to 2025), AbbVie's free cash flow has grown at a -5.1% compound annual growth rate (CAGR), from $21.99B to $17.82B.
- What does free cash flow mean?
- The cash a company has left over after paying for its operating expenses and capital investments.